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Helicobacter pylori dection constitutes the most common chronic 
bacterial infection worldwide. In developing countries, most of the 
population is mfected and acquisition of the dection occurs in early 
childhood, while in developed countries the rate of infection is pos- 
itively correlated with increasing age, explained by an observation 
which related to the existence of a cohort effect. Despite its high 
prevalence, H. pylori is not a commensal or saprophytic bacterium. 
In contrast to other Helicobacters, present in animal stomachs, H. 
pylori, the Helicobacter adapted to humans, constantly induces in- 
flammation and lays the groundwork for most of the major diseases 
of the stomach, including peptic ulcer and gastric cancer. Measures 
to prevent the transmission of this bacterium cannot be taken be- 
cause the mode of transmission is not known. Despite a colony of 
laboratory cats found to be infected, humans are considered the only 
source of mfection. In developing countries transmission via water 
and food is plausible. Contaminated water has been found, but only 
detected by PCR. Experimentally, flies exposed to H. pylori cul- 
tures can transport the bacteria. However, in developed countries 
direct person-to-person transmission is most likely, especially within 
families. Molecular fingerprinting has shown that transmission oc- 
curs probably between spouses and their children. Another potential 
hazard is linked to contact with gastric juice in the line of one’s 
profession. The wide distribution of the infection makes is a public 
health problem. 
worldwide perspective 
I S107 1 Helicobacterpylon- Within and Beyond the 
Digestive Tract 
J.J. Misiewicz. Department o j  Gastroenterology and Nutrition, Cenhal 
Middlesex Hospital NHS Tist, London N W 1  0, United Kingdom 
Colonisation of the foregut by Helicobacterpylori (Hp) is now believed 
to be one of the commonest chronic infections in the human. Hp 
infection, usually acquired in childhood, profoundly afTects gastric 
function, producing either increased (predominantly antral gastritis), 
or decreased (predominantly corpus gastritis) gastric acid secretion. 
Factors determining the Merential response to Hp infection are 
incompletely understood. The bacterium exhibits marked polymor- 
phism and toxic strains are increasingly characterised. Hp antritis is 
associated with increased risk of duodenal ulcer, Hp corpusitis with 
increased risk of gastric cancer. MALT lymphoma is also associated 
with Hp mfection and may remit on eradication of the organism. 
However, most infected subjects develop superficial chronic gastritis 
with no s i d c a n t  clinical consequences. The diagnosis and treat- 
ment of Hp infection has become very effective. Bacterial resistance 
to metronidazole or clarithromycin is an important and increasing 
problem. It has been suggested that conditions outside the alimen- 
tary tract may be associated with Hp mfection, but the evidence 
for this is incomplete. These comprises short stature, coronary heart 
disease, among others. 
The Role of H pylon in the Pathogenesis of 
Gastric MALT Lymphoma 
P.G. Isaacson. University College London Medical School, London, UK 
That lymphoma should arise h m  gastric mucosa is paradoxical since 
there is no lymphoid tissue in the normal stomach. Lymphoid tis- 
sue with the characteristics of MALT accumulates in gastric mucosa 
almost exclusively as a consequence of H pylori mfection. The din- 
ical, hlstological and molecular genetic propemes of low grade gas- 
tric MALT lymphoma suggest that its growth is influenced by a local 
antigen. Evidence for a link between H pylori and gastric lymphoma 
is the finding of H pylori in over 90% of cases of gastric MALT lym- 
phoma, the higher incidence of gastric lymphoma in communities 
with a high prevalence of H pylori and a case conml study show- 
ing that gastric lymphoma is commoner in patients with a history 
of infection with the organism. Laboratory studies have shown that 
the growth of tumour cells h m  low grade gastric lymphomas can 
be stimulated by H pylori and that the effect is strain specific and 
mediated by H pylori specific T-cells. Parallel c h c a l  studies have 
shown that cases of low grade gastric lymphoma, when confined 
to the mucosa, may regress following eradication of H pylori h m  
the patient’s stomach and that relapse of the mfection may lead to 
recurrence of lymphoma. 
I S109 I Extra-Gastrointestinal Manifestations of 
Helicobacter pylon Infection 
T.C. Northfield, M. M e n u .  St. George’s Medical School, London, 
UK 
The d r t y  chicken hypothesis (Solomans 1993) is based on the obser- 
vation that cluckens bred in overcrowded unhygienic condnions do 
not grow well. If these chickens are given antibiotics, their growth 
improves. It was postulated that a low grade systemic acute phase 
response may be responsible. We have postulated that H. pylori infec- 
tion may be producing a dmy chicken effect in man. It is associated 
with a low grade acute phase response, and the main risk factors for 
transmission are poor hygiene and overcrowdug. It is also associated 
with diminished growth in childhood and cardiovascular disease in 
adult life. The evidence is generally supportive of a moderate ef- 
fect, although confounding by social and economic factors cannot 
be ruled out. Most cardiovascular risk f5ctors are actually acute phase 
reactants. We are now carrying out interventional studies to check 
the effect of appropriate antibiotics on cardio risk factors and on 
mortality 
Strategies in Vaccine Development 
F! Michetti. Beth Israel Deaconess Medical Center, Boston, MA 
The high incidence of H. pylori dection worldwide, its potential 
complications and the rapid emergence of antibiotic resistance de- 
mand the development of novel measures of disease control, includ- 
ing vaccines. The feasability of latter approach was first supported by 
the demonstration that mice immunized orally with a lysate of Heli- 
cobacferfelis, a bacterium closely related to H. pylon’, were protected 
against subsequent challenge. Because of the poor characterization of 
bacterial lysates and their greater potential for side effects, the focus 
of vaccine development has shifted to the identification of protective 
antigens to be used as subunit vaccines with an adjuvant or to be 
expressed in live vaccine vectors. Several antigens of H. pylori are 
now considered vaccine candidates, including urease, VacA, and two 
heat shock proteins, HspB and HspA. Furthermore, we and others 
demonstrated that therapeutic immunization was possible against an 
established infection, opening the possibility to use vaccination as 
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a therapy. Protection and cure have been associated with increased 
antigen-specific T H ~  cell responses. The role ofsecretory IgA and/or 
of IgG in the protection of the gastric mucosa remains however un- 
clear. We also showed that oral immunization with urease was safe 
in H. pylori-infected humans and could reduce the density of infec- 
tion. Further developments include the use less toxic adjuvants or of 
live vaccine vectors, the determination of the optimal immunization 
procedure to induce protection of the gastric mucosa as well asthe 
use of combinations of antigens. 
The Carbapenem Decade 
Comparative Evaluation of Carbapenems in 
lntra-Abdominal Infections 
A. Basoli, V Speranza. Clinica Chiturgica II. Universitd "Ln Sapienzu", 
Policlinuo Umberto I. 00161 Rome, Italy 
Objectives: Imipenem/dastatin (I/C) has been shown to be highly 
effective as monotherapy in the treatment of intra-abdominal mfec- 
dons. Meropenem (Me), a carbapenem with an I/C like spectrum 
of activity, has been reported in two recent clinical trials (in one I/C 
3 grvs Me 3 grday and in the other I/C 1.5 grvs Me 1.5 gr day) 
to have as good a safety and efficacy profile as I/C. The aim of ths 
paper is to compare the results obtained in the three trials. 
Methods: We undertook an open label, prospective, randomized, 
parallel multicenter study to compare the efficacy and tolerabLity 
of 1.5 gr of I/C with 3 gr of Me day. These dosages were chosen 
because: 1 Me is recommen$ed at 3 gr/day in intra-abdominal in- 
fections while I/C is effective at 1.5 gr, 2 I/C has greater activity 
on Enterococcus (four times higher). Of 287 patients enrolled in 20 
centers, 201 patients were evaluable (101 randomized to I/C and 
100 to Me). In the 86 (31.8%) non evaluable patients 94.1% were 
excluded owing to failure to recover susceptible pathogens. Compar- 
ative analysis shows that our patients were more severe than those in 
the other studes: fewer cases of appendicitis (15% vs 35% and 73%) 
and more cases in the moderate severe group according to APACHE 
I1 score. 
Results: Although the Jirucal and bacteriological outcome were 
not s'gtllficantly Merent, at the staft of our study with I/C, 9 
pathogens sensitive to I/C were resistant to Me and of the 15 En- 
terococcus sp. sensitive to I/C 6 were resistant to Me. Furthermore, 
in our study both the mean time to defervescence (1.83 days vs 2.46 
days p = 0.046) and the average duration of therapy (6.7 days vs 4.2 
days = 0.019) were sigruficantly shorter in the I/C group. Seizures 
did not occur in any of the trials even when 1 gr/8 hr of I/C was 
employed. 
Conclusions: The fact that I/C was clinically efficacious at half 
the dosage of Me and required a shorter duration of treatment, even 
though the patients treated with I/C appeared to be more severe that 
those in the Me group clearly suggests that I/C is sigruficantly more 
cost effective, at least with respect to the cost of the antibiotic itself. 
I s112 1 Extended-Spectnrm Beta-lactamases: 
Epidemiology and Clinical Implications 
J.P Quinn. UIC College OfMedicine, Dept. OfMedicine, 1020 N 
Clinical sciences Building, 840 South Wood Street, Chiago, IL 
60612-7323, USA 
Gram negative pathogens harboring extended-spectrum beta-lac- 
tamases (ESBLs) are becoming an increasing therapeutic problem 
globally. We have recently published an analysis of an in-vim re- 
sistance survey among 33,869 gram negative organisms fivm 396 
intensive care units in the United States. The prevalence of cef- 
tazidime-resistance among Klebsiella is0late.s in this survey rose fivm 
3.6% to 14.4% between 1990 and 1993 (Itokazu. Clin Inject Dis  
1996; 23: 779). 
A molecular epidemiologic investigation of an epidemic of 31 
bloodstream infections with multi-resistant Mebsielh and E. coli in a 
university hospital in Chicago revealed that most cases occurred in 
debilitated nursing home (NH) patients who were instrumented, had 
hlgh APACHE scores, and had recently been treated with antibi- 
otia, especially extended-spectrum cephalosporins (ESCs). In h 
outbreak and in a similar epidemic reported in 1993 &om a hospital 
in New York City, patiena treated wth  imipenem and/or amikacin 
had a higher sunrival rate than those treated with ESCs (Schiappa. 1 
Infea Dis 1996; 174  529). 
We are currently investigating a city wide outbreak of 
ESBL-producing pathogens among NH patients admitted to 6 
Chicago hospitals mediated by a common 54 Kb plasmid. Prior 
exposure to oral TMP-SMX and/or quinolones was a risk factor for 
colonization mth an ESBL-producer in ths study. 
[s1131 Reduction of Cyclosporin Nephrotoxicity in 
Transplant Patients 
S. Zahan. D 
No abstract available. 
I S114 I The Economics of a New Delivery System 
H. Robays. Pharmacy Services UZG, De P i n t e h n  185, B-9000, 
GEN?; Belgium 
Objectives: to explain the Werencies between the Werent prepa- 
ration methods of IV drugs. 
Methodology: the conventional methods, i.e. syringe-needle and 
m f e r t  needle were compared with the Monovial @, a drug con- 
tainer with an integrated transfer system. In a first step all relevant 
costs of each method were established and the cost of each activity 
was calculated. In a third step these global costs were calculated for 
a sample of 10 drugs commonly used in the hospital. Finally the 
opinion of 31 nurses was examined by means of two open and 9 
score statements. 
Results: the transfer-needle method was the most expensive way 
to prepare drugs for IV administration (31.73 BEF) followed by the 
syringe-needle method (23.23 BEF). M o n o d  @ is the cheapest 
method for the preparation of IV drug administration (10.71 BEF). 
In the general opinion of the nurses, the preparation of IV drugs by 
means of the Monovial @ is an improvement in terms of speed, ease 
of use and reduces of the amount of waste, d e t y  and aepsy. 
Conclusion: new administration dmces can diminish prepara- 
tion time. 
I S115 I Microbiological Overview of the Carbapenems 
D.M. Livermore. St. Burtholomew's 6 the Royal London .School of 
Medicine G Dentise, London E l  2AD, United Kingdom 
The carbapenems are formidable antimicrobials, with broader spec- 
tra than any other B-lactam. Of the compounds available, imipenem 
has been widely used for 12 years and meropenem for 2; pa- 
nipenem is used in Japan, not elsewhere. Meropenem is the 
most active apns t  gram-negative bacteria, imipenem the most ac- 
tive against agatnst gram-positive cocci. All rerain activity against 
AmpC-derepressed enterobacteria and those with ESBLs. To date, F! 
